Last updated: 15 June 2019 at 11:15pm EST

Marcel Veronneau Net Worth




The estimated Net Worth of Marcel Veronneau is at least 2.57 百万$ dollars as of 8 June 2015. Marcel Veronneau owns over 385 units of Bio-Techne Corp stock worth over 2,571,342$ and over the last 22 years Marcel sold TECH stock worth over 0$.

Marcel Veronneau TECH stock SEC Form 4 insiders trading

Marcel has made over 5 trades of the Bio-Techne Corp stock since 2011, according to the Form 4 filled with the SEC. Most recently Marcel exercised 385 units of TECH stock worth 30,573$ on 8 June 2015.

The largest trade Marcel's ever made was exercising 567 units of Bio-Techne Corp stock on 1 July 2013 worth over 28,027$. On average, Marcel trades about 87 units every 53 days since 2003. As of 8 June 2015 Marcel still owns at least 34,989 units of Bio-Techne Corp stock.

You can see the complete history of Marcel Veronneau stock trades at the bottom of the page.



What's Marcel Veronneau's mailing address?

Marcel's mailing address filed with the SEC is , , , , .

Insiders trading at Bio-Techne Corp

Over the last 22 years, insiders at Bio-Techne Corp have traded over 37,160,097$ worth of Bio-Techne Corp stock and bought 4,361 units worth 454,370$ . The most active insiders traders include Charles R. KummethRupert VesseyJohn L Higgins. On average, Bio-Techne Corp executives and independent directors trade stock every 23 days with the average trade being worth of 964,850$. The most recent stock trade was executed by Kim Kelderman on 29 August 2024, trading 1,492 units of TECH stock currently worth 99,919$.



What does Bio-Techne Corp do?

bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.



Complete history of Marcel Veronneau stock trades at Bio-Techne Corp

インサイダー
取引
取引
合計金額
Marcel Veronneau
Vice Pres-Hematology Oper.
オプション行使 30,573$
8 Jun 2015
Marcel Veronneau
Vice Pres-Hematology Oper.
オプション行使 28,983$
2 Jun 2014
Marcel Veronneau
Vice Pres-Hematology Oper.
オプション行使 28,027$
1 Jul 2013
Marcel Veronneau
Vice Pres-Hematology Oper.
オプション行使 24,510$
14 Aug 2012
Marcel Veronneau
Vice Pres-Hematology Oper.
オプション行使 20,437$
26 May 2011


Bio-Techne Corp executives and stock owners

Bio-Techne Corp executives and other stock owners filed with the SEC include: